Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazushi Inoue

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Biomarkers in Cancer|March 22, 2016
Novel Molecular Markers for Breast CancerKazushi Inoue, Elizabeth A Fry
Integrative Cancer Science and Therapeutics|January 31, 2017
Clinical applications of mouse models for breast cancer engaging HER2/neuElizabeth A Fry, Pankaj Taneja, Kazushi Inoue
International Journal of Cancer|August 25, 2016
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neuElizabeth A Fry, Pankaj Taneja, Kazushi Inoue
Integrative Cancer Science and Therapeutics|December 14, 2018
Translocations involving ETS family proteins in human cancerElizabeth A Fry, Ali Mallakin, Kazushi Inoue
Clinical Medicine Insights. Oncology|July 12, 2013
Recent progress in mouse models for tumor suppressor genes and its implications in human cancerKazushi Inoue, Elizabeth A Fry, Pankaj Taneja
International Journal of Cancer|July 2, 2015
Transcription factors that interact with p53 and Mdm2Kazushi Inoue, Elizabeth A Fry, Donna P Frazier
The Journal of Biological Chemistry|September 13, 2006
Induction of transcriptionally active Jun proteins regulates drug-induced senescenceOrli Yogev, Shira Anzi, Kazushi Inoue, et al.
Critical Reviews in Oncogenesis|January 18, 2012
The oncogenic role of Yin Yang 1Qiang Zhang, Daniel B Stovall, Kazushi Inoue, et al.
Cancer Investigation|April 14, 2017
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1αRobert D Kendig, Fumitake Kai, Elizabeth A Fry, et al.
Cancer Research|March 5, 2008
DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathwayOrli Yogev, Keren Saadon, Shira Anzi, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Biomarkers in Cancer|March 22, 2016
Novel Molecular Markers for Breast CancerKazushi Inoue, Elizabeth A Fry
Integrative Cancer Science and Therapeutics|January 31, 2017
Clinical applications of mouse models for breast cancer engaging HER2/neuElizabeth A Fry, Pankaj Taneja, Kazushi Inoue
International Journal of Cancer|August 25, 2016
Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neuElizabeth A Fry, Pankaj Taneja, Kazushi Inoue
Integrative Cancer Science and Therapeutics|December 14, 2018
Translocations involving ETS family proteins in human cancerElizabeth A Fry, Ali Mallakin, Kazushi Inoue
Clinical Medicine Insights. Oncology|July 12, 2013
Recent progress in mouse models for tumor suppressor genes and its implications in human cancerKazushi Inoue, Elizabeth A Fry, Pankaj Taneja
International Journal of Cancer|July 2, 2015
Transcription factors that interact with p53 and Mdm2Kazushi Inoue, Elizabeth A Fry, Donna P Frazier
The Journal of Biological Chemistry|September 13, 2006
Induction of transcriptionally active Jun proteins regulates drug-induced senescenceOrli Yogev, Shira Anzi, Kazushi Inoue, et al.
Critical Reviews in Oncogenesis|January 18, 2012
The oncogenic role of Yin Yang 1Qiang Zhang, Daniel B Stovall, Kazushi Inoue, et al.
Cancer Investigation|April 14, 2017
Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1αRobert D Kendig, Fumitake Kai, Elizabeth A Fry, et al.
Cancer Research|March 5, 2008
DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathwayOrli Yogev, Keren Saadon, Shira Anzi, et al.
Pageof 4